Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 201–300 of 1,005
Yan, Y., Huang, L., Liu, Y., Yi, M., Chu, Q., Jiao, D., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01322-3 · Cited by 212
“Pharmacological inhibition of CPT1 through etomoxir restrained the proliferation of Tregs [85].”
BackgroundInfluentialPI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances
So, L., & Fruman, D. A. (2012) · Biochemical Journal · doi:10.1042/bj20112092 · Cited by 218
Metabolic control of the Treg/Th17 axis
Barbi, J., Pardoll, D., & Pan, F. (2013) · Immunological Reviews · doi:10.1111/imr.12029 · Cited by 217
“Moreover, in vivo administration of metformin was sufficient to decrease Glut1 expression and increase Treg numbers in an asthma model (79).”
BackgroundResultInfluentialImmunometabolic circuits in trained immunity
Arts, R. J. W., Joosten, L. A. B., & Netea, M. G. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.002 · Cited by 213
Michalek, R. D., Gerriets, V. A., Nichols, A. G., Inoue, M., Kazmin, D., Chang, C.-Y., Dwyer, M. A., Nelson, E. R., Pollizzi, K. N., Ilkayeva, O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108856108 · Cited by 216
“In addition to growth and proliferation, increased T-cell metabolism is critical for the differentiation of Teff and Treg cells, with Teff preferentially using glycolytic metabolism and Treg using lipid oxidation (6).”
BackgroundMethodSelf-citationMenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
Jones, R. G., & Pearce, E. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.028 · Cited by 212
Modification of Proteins by Metabolites in Immunity
Diskin, C., Ryan, T. A. J., & O’Neill, L. A. J. (2021) · Immunity · doi:10.1016/j.immuni.2020.09.014 · Cited by 209
Biological drug and drug delivery-mediated immunotherapy
Xiao, Q., Li, X., Li, Y., Wu, Z., Xu, C., Chen, Z., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.018 · Cited by 211
Metabolic Pathways Involved in Regulatory T Cell Functionality
Kempkes, R. W. M., Joosten, I., Koenen, H. J. P. M., & He, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02839 · Cited by 211
mTOR Regulation of Glycolytic Metabolism in T Cells
Salmond, R. J. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00122 · Cited by 211
“Based on the use of chemical inhibitors, FAO has also been suggested to be important for the development of memory T cells (reviewed in (Lochner et al., 2015)); although recent evidence using genetic mouse models suggest that the requirement for FAO is not absolute (Pan et al., 2017; Raud et al., 2018).”
BackgroundInfluentialDifferential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis
Cluxton, D., Petrasca, A., Moran, B., & Fletcher, J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00115 · Cited by 207
Metabolic Barriers to T Cell Function in Tumors
Sugiura, A., & Rathmell, J. C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701041 · Cited by 208
“cells induced in culture as well as in in vivo model of inflammatory disease, and glucose-deficient conditions instead promote Treg cell induction and suppressive activity in vitro (13, 14, 28).”
BackgroundInfluentialSelf-citationMetformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase
Park, C. S., Bang, B.-R., Kwon, H.-S., Moon, K.-A., Kim, T.-B., Lee, K.-Y., Moon, H.-B., & Cho, Y. S. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.025 · Cited by 208
Phan, A. T., Doedens, A. L., Palazon, A., Tyrakis, P. A., Cheung, K. P., Johnson, R. S., & Goldrath, A. W. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.017 · Cited by 208
“These data parallel studies in CD4 T cells where particular T helper (Th) subsets, which express distinct master transcription factors, exhibit differential reliance on metabolic pathways for differentiation and function (Dang et al., 2011; De Rosa et al., 2015; Mascanfroni et al., 2015; Michalek et al., 2011; Shi et…”
BackgroundResultHypoxia, Metabolism and Immune Cell Function
Krzywinska, E., & Stockmann, C. (2018) · Biomedicines · doi:10.3390/biomedicines6020056 · Cited by 208
“They have found that pro-inflammatory TH1, TH2 and TH17 lymphocytes after in vitro stimulation preferentially use glycolytic metabolism, contrary to in vitro activated regulatory T cells, which display increased lipid oxidation and oxidative phosphorylation [93,163].”
BackgroundThe CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
O’Connor, R. S., Guo, L., Ghassemi, S., Snyder, N. W., Worth, A. J., Weng, L., Kam, Y., Philipson, B., Trefely, S., Nunez-Cruz, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24676-6 · Cited by 206
Role of Lactate in Inflammatory Processes: Friend or Foe
Manosalva, C., Quiroga, J., Hidalgo, A. I., Alarcón, P., Ansoleaga, N., Hidalgo, M. A., & Burgos, R. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.808799 · Cited by 205
“It has been shown that macrophage metabolism can in fl uence in fl ammatory cytokine production, and the same has been demonstrated in T cells (82), myeloid-derived suppressor cells (MDSC) (83), and dendritic cells (DC) (84).”
Son, H.-J., Lee, J., Lee, S.-Y., Kim, E.-K., Park, M.-J., Kim, K.-W., Park, S.-H., & Cho, M.-L. (2014) · Mediators of Inflammation · doi:10.1155/2014/973986 · Cited by 206
Wilhelm, C., Harrison, O. J., Schmitt, V., Pelletier, M., Spencer, S. P., Urban, J. F., Ploch, M., Ramalingam, T. R., Siegel, R. M., & Belkaid, Y. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151448 · Cited by 203
Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity
Shi, H., & Chi, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02716 · Cited by 202
“In contrast, glucose deprivation can drive Foxp3 expression, shifting T cell differentiation from conventional T cells toward iTreg cells (16, 78, 207).”
BackgroundInfluentialT‐cell metabolism governing activation, proliferation and differentiation; a modular view
Dimeloe, S., Burgener, A., Grählert, J., & Hess, C. (2017) · Immunology · doi:10.1111/imm.12655 · Cited by 201
Regulation of T cells by mTOR: the known knowns and the known unknowns
Pollizzi, K. N., & Powell, J. D. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.11.005 · Cited by 200
“findings seem to fit with data demonstrating that effector CD4+ T cells are highly glycolytic, while regulatory T cells are less glycolytic and employ to a greater degree than effector cells, fatty acid metabolism [45].”
ResultImmunometabolism in the Single-Cell Era
Artyomov, M. N., & Van den Bossche, J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.09.013 · Cited by 200
Cytokine-like Roles for Metabolites in Immunity
Zasłona, Z., & O’Neill, L. A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.002 · Cited by 199
Lian, G., Gnanaprakasam, J. R., Wang, T., Wu, R., Chen, X., Liu, L., Shen, Y., Yang, M., Yang, J., Chen, Y., et al. (2018) · eLife · doi:10.7554/elife.36158 · Cited by 196
“TH17 and iTreg cells display different degrees of oxidative stress Accumulating evidence has shown that each subset of T cells engages unique metabolic pathways to fulfill its metabolic demands (Shi et al., 2011; Michalek et al., 2011; Gerriets et al., 2015).”
BackgroundInfluentialMetabolism in tumor microenvironment: Implications for cancer immunotherapy
Shi, R., Tang, Y., & Miao, H. (2020) · MedComm · doi:10.1002/mco2.6 · Cited by 198
Metabolic Reprogramming in Immune Response and Tissue Inflammation
Sun, L., Yang, X., Yuan, Z., & Wang, H. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314037 · Cited by 189
The Cellular and Molecular Basis of Translational Immunometabolism
Norata, G. D., Caligiuri, G., Chavakis, T., Matarese, G., Netea, M. G., Nicoletti, A., O’Neill, L. A. J., & Marelli-Berg, F. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.023 · Cited by 196
“Regarding Treg cells, it has been shown that lipid oxidation is the key metabolic program sustaining their in vitro proliferation and function (Michalek et al., 2011).”
BackgroundFasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses
Nagai, M., Noguchi, R., Takahashi, D., Morikawa, T., Koshida, K., Komiyama, S., Ishihara, N., Yamada, T., Kawamura, Y. I., Muroi, K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.047 · Cited by 196
Intermediates of Metabolism: From Bystanders to Signalling Molecules
Haas, R., Cucchi, D., Smith, J., Pucino, V., Macdougall, C. E., & Mauro, C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.02.003 · Cited by 193
“Treatment with etomoxir, an inhibitor of carnitine palmitoyl transferase (CPT1), the rate-limiting enzyme in FAO, was sufficient to abrogate Treg development, suggesting that FAO is essential for Treg development [55].”
BackgroundChapman, N. M., Zeng, H., Nguyen, T.-L. M., Wang, Y., Vogel, P., Dhungana, Y., Liu, X., Neale, G., Locasale, J. W., & Chi, H. (2018) · Nature Communications · doi:10.1038/s41467-018-04392-5 · Cited by 192
Kabat, A. M., Harrison, O. J., Riffelmacher, T., Moghaddam, A. E., Pearson, C. F., Laing, A., Abeler-Dörner, L., Forman, S. P., Grencis, R. K., Sattentau, Q., et al. (2016) · eLife · doi:10.7554/elife.12444 · Cited by 193
“Interestingly, TH2 cells have previously been shown to display an increased glycolytic rate compared to other TH subsets (Michalek et al., 2011; Yang et al., 2013).”
BackgroundmTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
Huang, H., Long, L., Zhou, P., Chapman, N. M., & Chi, H. (2020) · Immunological Reviews · doi:10.1111/imr.12845 · Cited by 193
Immunotherapy for cardiovascular disease
Lutgens, E., Atzler, D., Döring, Y., Duchene, J., Steffens, S., & Weber, C. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz283 · Cited by 192
Knudsen, E. S., Vail, P., Balaji, U., Ngo, H., Botros, I. W., Makarov, V., Riaz, N., Balachandran, V., Leach, S., Thompson, D. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0162 · Cited by 191
“In contrast, regulatory T cells and macrophages are capable of utilizing fatty acid oxidation to survive in low-glucose environment (53, 54).”
Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation
Hao, F., Tian, M., Zhang, X., Jin, X., Jiang, Y., Sun, X., Wang, Y., Peng, P., Liu, J., Xia, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014681118 · Cited by 187
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Guerra, L., Bonetti, L., & Brenner, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107848 · Cited by 189
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
Miguel, V., Shaw, I. W., & Kramann, R. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00889-z · Cited by 181
The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival
Howie, D., Ten Bokum, A., Necula, A. S., Cobbold, S. P., & Waldmann, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01949 · Cited by 187
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Cassim, S., & Pouyssegur, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010157 · Cited by 188
“As reported in murine models, Treg cells express low levels of GLUT-1 and do not depend on glucose uptake and glycolysis [51].”
BackgroundSzukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129818 · Cited by 189
“By regulating lipid metabolism and calming the inflammatory response, PPARs may also influence Treg survival [257].”
Nutritional effects on T‐cell immunometabolism
Cohen, S., Danzaki, K., & MacIver, N. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646423 · Cited by 187
Self-citationCAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
Knochelmann, H. M., Smith, A. S., Dwyer, C. J., Wyatt, M. M., Mehrotra, S., & Paulos, C. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01740 · Cited by 187
“Conversely, memory and Treg cells operate using mitochondrial metabolism and fatty acid β-oxidation in a similar manner as naïve T cells (156).”
BackgroundShort‐chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells
Luu, M., & Visekruna, A. (2019) · European Journal of Immunology · doi:10.1002/eji.201848009 · Cited by 186
Nicolini, A., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353787 · Cited by 182
Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
Boussiotis, V. A., Chatterjee, P., & Li, L. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000059 · Cited by 185
“Furthermore, enforcing FAO by pharmacologic means promotes the generation of Treg cells.(80) We investigated the metabolism of T cells receiving PD-1 signals, and we discovered that they were unable to engage in glycolysis, glutaminolysis, or metabolism of branched chain amino acids but displayed increased rate of FAO.”
BackgroundCaldwell, J. M., Collins, M. H., Stucke, E. M., Putnam, P. E., Franciosi, J. P., Kushner, J. P., Abonia, J. P., & Rothenberg, M. E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.026 · Cited by 185
Gomez-Rodriguez, J., Wohlfert, E. A., Handon, R., Meylan, F., Wu, J. Z., Anderson, S. M., Kirby, M. R., Belkaid, Y., & Schwartzberg, P. L. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131459 · Cited by 180
“…and Pearce, 2012); although effector CD4 cells activate glycolytic pathways, Treg cells exhibit depressed glycolysis and reduced expression of glucose transporters and glycolytic enzymes compared with effector CD4+ T cell populations (Michalek et al., 2011; Xu et al., 2012; MacIver et al., 2013).”
BackgroundGlucose, glycolysis and lymphocyte responses
Donnelly, R. P., & Finlay, D. K. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.034 · Cited by 182
Classification of T-cell activation via autofluorescence lifetime imaging
Walsh, A. J., Mueller, K. P., Tweed, K., Jones, I., Walsh, C. M., Piscopo, N. J., Niemi, N. M., Pagliarini, D. J., Saha, K., & Skala, M. C. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0592-z · Cited by 175
Tarasenko, T. N., Pacheco, S. E., Koenig, M. K., Gomez-Rodriguez, J., Kapnick, S. M., Diaz, F., Zerfas, P. M., Barca, E., Sudderth, J., DeBerardinis, R. J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.007 · Cited by 178
“Differential Effects of COX Dysfunction on Effector CD4 T Cell Subsets Based on our observation demonstrating the vulnerability of CD8 T cell subsets, and the discrete metabolic programs adopted by effector and regulatory T cells (Gerriets et al., 2015; Michalek et al., 2011), we hypothesized that T helper (Th) subset…”
Kabacaoglu, D., Ciecielski, K. J., Ruess, D. A., & Algül, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01878 · Cited by 179
Preventing Allograft Rejection by Targeting Immune Metabolism
Lee, C.-F., Lo, Y.-C., Cheng, C.-H., Furtmüller, G. J., Oh, B., Andrade-Oliveira, V., Thomas, A. G., Bowman, C. E., Slusher, B. S., Wolfgang, M. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.036 · Cited by 177
“Alternatively, regulatory T cells (Tregs) are not dependent upon glycolysis and appear to rely more on lipid oxidation to generate energy (Huynh et al., 2015; Michalek et al., 2011).”
BackgroundMetabolic reprogramming and metabolic dependency in T cells
Wang, R., & Green, D. R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01155.x · Cited by 176
“Similarly, etoxomir significantly inhibited Treg differentiation in vitro (28, 31).”
BackgroundInfluentialDowns-Canner, S., Berkey, S., Delgoffe, G. M., Edwards, R. P., Curiel, T., Odunsi, K., Bartlett, D. L., & Obermajer, N. (2017) · Nature Communications · doi:10.1038/ncomms14649 · Cited by 177
Effects of tumor metabolic microenvironment on regulatory T cells
Wang, Y.-A., Li, X.-L., Mo, Y.-Z., Fan, C.-M., Tang, L., Xiong, F., Guo, C., Xiang, B., Zhou, M., Ma, J., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0913-y · Cited by 176
Metabolic adaptations of tissue-resident immune cells
Caputa, G., Castoldi, A., & Pearce, E. J. (2019) · Nature Immunology · doi:10.1038/s41590-019-0407-0 · Cited by 176
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
Dhillon, P., Park, J., Hurtado del Pozo, C., Li, L., Doke, T., Huang, S., Zhao, J., Kang, H. M., Shrestra, R., Balzer, M. S., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.011 · Cited by 174
AIM2 in regulatory T cells restrains autoimmune diseases
Chou, W.-C., Guo, Z., Guo, H., Chen, L., Zhang, G., Liang, K., Xie, L., Tan, X., Gibson, S. A., Rampanelli, E., et al. (2021) · Nature · doi:10.1038/s41586-021-03231-w · Cited by 173
Escoll, P., & Buchrieser, C. (2018) · The FEBS Journal · doi:10.1111/febs.14446 · Cited by 169
Hosseinzade, A., Sadeghi, O., Naghdipour Biregani, A., Soukhtehzari, S., Brandt, G. S., & Esmaillzadeh, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00051 · Cited by 171
Impact of intracellular innate immune receptors on immunometabolism
Chou, W.-C., Rampanelli, E., Li, X., & Ting, J. P.-Y. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00780-y · Cited by 172
“The marked dependence on glycolysis has been largely studied in classically activated M1 macrophages, monocytes, and effector T-helper 1 and 17 (Th1/17) cells [3, 6, 9, 11, 15], but glycolysis is a hallmark of all activated immune cells, including activated dendritic cells (DCs), neutrophils, B cells, and natural kill…”
BackgroundZhang, Z., Zi, Z., Lee, E. E., Zhao, J., Contreras, D. C., South, A. P., Abel, E. D., Chong, B. F., Vandergriff, T., Hosler, G. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0003-0 · Cited by 171
Self-citationThe Metabolic Requirements of Th2 Cell Differentiation
Stark, J. M., Tibbitt, C. A., & Coquet, J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02318 · Cited by 170
“During initial activation, glycolysis becomes the dominant metabolic pathway in T helper cells (51).”
BackgroundPalmer, C. S., Ostrowski, M., Gouillou, M., Tsai, L., Yu, D., Zhou, J., Henstridge, D. C., Maisa, A., Hearps, A. C., Lewin, S. R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000128 · Cited by 170
“Upon activation, the energy demands of T cells increase dramatically and they undergo a metabolic switch in glucose metabolism from oxidative phosphorylation to aerobic glycolysis, so that growth, proliferation, and effector functions can be supported [15] (and as reviewed in references [16–19]).”
BackgroundMitochondrial function, ornamentation, and immunocompetence
Koch, R. E., Josefson, C. C., & Hill, G. E. (2017) · Biological Reviews · doi:10.1111/brv.12291 · Cited by 171
“Regulatory T cells, for example, rely on increased oxidative phosphorylation compared to helper T17 cells, which instead exhibit increased glycolytic activity to meet biosynthetic needs (Michalek et al., 2011; Walker et al., 2014).”
BackgroundAhl, P. J., Hopkins, R. A., Xiang, W. W., Au, B., Kaliaperumal, N., Fairhurst, A.-M., & Connolly, J. E. (2020) · Communications Biology · doi:10.1038/s42003-020-1027-9 · Cited by 170
Mitochondrial mass governs the extent of human T cell senescence
Callender, L. A., Carroll, E. C., Bober, E. A., Akbar, A. N., Solito, E., & Henson, S. M. (2020) · Aging Cell · doi:10.1111/acel.13067 · Cited by 169
“The in vitro generation of Th1, Th2 and Th17 CD4+ T cell subsets was all found to utilize glycolysis, whereas T regulatory cells favoured mitochondrial oxidative pathways (Michalek et al., 2011).”
BackgroundTargeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases
Chávez, M. D., & Tse, H. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703972 · Cited by 164
Huang, L., Xu, H., & Peng, G. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2018.4 · Cited by 164
Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation
Lyons, C. L., & Roche, H. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103092 · Cited by 163
“T regulatory cells require lipid metabolism for their differentiation which is mediated by AMPK where metformin administration to mice increases the number of T reg cells [60].”
BackgroundMitochondrial activity in T cells
Desdín-Micó, G., Soto-Heredero, G., & Mittelbrunn, M. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.10.006 · Cited by 161
Mechanisms underlying helper T-cell plasticity: Implications for immune-mediated disease
Hirahara, K., Poholek, A., Vahedi, G., Laurence, A., Kanno, Y., Milner, J. D., & O’Shea, J. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.015 · Cited by 161
Foxp3 Post-translational Modifications and Treg Suppressive Activity
Deng, G., Song, X., Fujimoto, S., Piccirillo, C. A., Nagai, Y., & Greene, M. I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02486 · Cited by 162
Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis
Qiu, J., Wu, B., Goodman, S. B., Berry, G. J., Goronzy, J. J., & Weyand, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652771 · Cited by 159
Glucose-dependent de Novo Lipogenesis in B Lymphocytes
Dufort, F. J., Gumina, M. R., Ta, N. L., Tao, Y., Heyse, S. A., Scott, D. A., Richardson, A. D., Seyfried, T. N., & Chiles, T. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551051 · Cited by 160
The “ins and outs” of complement‐driven immune responses
Freeley, S., Kemper, C., & Le Friec, G. (2016) · Immunological Reviews · doi:10.1111/imr.12472 · Cited by 161
“and Th17 cell responses, whereas mTORC2 drives Th2 cell function (140, 149, 150).”
BackgroundMetabolic control of regulatory T cell (Treg) survival and function by Lkb1
He, N., Fan, W., Henriquez, B., Yu, R. T., Atkins, A. R., Liddle, C., Zheng, Y., Downes, M., & Evans, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715363114 · Cited by 160
“The tailoring of cellular metabolism to discrete T cell subsets is central for proper T cell differentiation and function (2, 3).”
BackgroundRegulatory T cell adaptation in the intestine and skin
Whibley, N., Tucci, A., & Powrie, F. (2019) · Nature Immunology · doi:10.1038/s41590-019-0351-z · Cited by 160
Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential
Wang, L., Liang, Y., Zhao, C., Ma, P., Zeng, S., Ju, D., Zhao, M., Yu, M., & Shi, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02326-4 · Cited by 210
“148,149 153 – 156 Fatty acid binding protein 5 (FABP5) is a member of the lipid chaperone family.”
Dysfunctional T cell metabolism in the tumor microenvironment
Beckermann, K. E., Dudzinski, S. O., & Rathmell, J. C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.003 · Cited by 159
“AMPK activation can promote generation of Treg in vivo [37] and AMPKa1 is also necessary for the development of Th1 and Th17 development during acute infection, likely by mitigating metabolic stress [38].”
BackgroundSelf-citationImmune Regulation in Obesity-Associated Adipose Inflammation
Han, J. M., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301035 · Cited by 157
Kaufmann, U., Kahlfuß, S., Yang, J. J. J., Ivanova, E., Koralov, S. B., & Feske, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.019 · Cited by 162
Cellular Metabolism in Lung Health and Disease
Liu, G., & Summer, R. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114640 · Cited by 157
Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
Lu, J., Zhao, J., Meng, H., & Zhang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01173 · Cited by 156
Functional and Phenotypic Plasticity of CD4+T Cell Subsets
Caza, T. N., & LANDAS, S. K. (2015) · BioMed Research International · doi:10.1155/2015/521957 · Cited by 208
“the Glut1 receptor to facilitate increased glucose transport [102].”
BackgroundNicholas, D. A., Proctor, E. A., Agrawal, M., Belkina, A. C., Van Nostrand, S. C., Panneerseelan-Bharath, L., Jones, A. R., Raval, F., Ip, B. C., Zhu, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.004 · Cited by 153
Metabolic reprogramming consequences of sepsis: adaptations and contradictions
Liu, J., Zhou, G., Wang, X., & Liu, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04490-0 · Cited by 180
“When GLUT1 expression is depressed, glucose uptake and glycolysis are significantly inhibited, along with a significant decrease in Teff's vital and functional activities [29, 40].”
BackgroundPrice, M. J., Patterson, D. G., Scharer, C. D., & Boss, J. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.053 · Cited by 165
“Similar to proliferating T cells, proliferating B cells upregulate glycolysis (Chang et al., 2013; MacIver et al., 2013; Michalek et al., 2011).”
BackgroundKumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 186
Treg(s) in Cancer: Friends or Foe?
Wolf, D., Sopper, S., Pircher, A., Gastl, G., & Wolf, A. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25016 · Cited by 151
Siska, P. J., van der Windt, G. J. W., Kishton, R. J., Cohen, S., Eisner, W., MacIver, N. J., Kater, A. P., Weinberg, J. B., & Rathmell, J. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502464 · Cited by 151
Self-citationThe role of AMPK in T cell metabolism and function
Ma, E. H., Poffenberger, M. C., Wong, A., & Jones, R. G. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.004 · Cited by 164
Metabolism Controls the Balance of Th17/T-Regulatory Cells
Sun, L., Fu, J., & Zhou, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01632 · Cited by 150
Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
Steinert, E. M., Vasan, K., & Chandel, N. S. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-082015 · Cited by 173
The role of Th17 cells in inflammatory bowel disease and the research progress
Chen, L., Ruan, G., Cheng, Y., Yi, A., Chen, D., & Wei, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055914 · Cited by 190
Francisco, J. J., & Re, D. P. D. (2023) · Antioxidants · doi:10.3390/antiox12111944 · Cited by 192
“Conversely, Tregs express lower levels of Glut1 and exhibit greater fatty acid oxidative and mitochondrial respiration, suggesting that reduced reliance on glycolysis may underly the anti-inflammatory function in these cells [100,148,149].”
BackgroundCao, Y., Rathmell, J. C., & Macintyre, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104104 · Cited by 150
“Mice expressing endogenous levels of myc-epitope tagged Glut1 (Glut1) have been described previously [2].”
BackgroundMethodInfluentialSelf-citationMitochondria: An Organelle of Bacterial Origin Controlling Inflammation
Meyer, A., Laverny, G., Bernardi, L., Charles, A. L., Alsaleh, G., Pottecher, J., Sibilia, J., & Geny, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00536 · Cited by 151
“In vitro, etomoxir, an inhibitor of carnitine palmitoyltransferase-1 on the outer face of the inner mitochondrial membrane, impairs diffe rentiation into Treg, but does not affect differentiation into proinflammatory Th cells (63).”
BackgroundTargeting T Cell Metabolism for Improvement of Cancer Immunotherapy
Le Bourgeois, T., Strauss, L., Aksoylar, H.-I., Daneshmandi, S., Seth, P., Patsoukis, N., & Boussiotis, V. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00237 · Cited by 152
“In that model, pharmacologic inhibition of FAO decreased the production of inhibitory cytokines and blocked the immunosuppressive functions of tumor-infiltrating MDSCs. FAO inhibition also delayed tumor growth and enhanced the antitumor efficacy of adoptive T cell therapy.”
BackgroundInfluential
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.